Hôpital Beaujon
Hôpital Beaujon
Paris, France5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 4 | 2026-07-22 | NCT07718529 | |
| MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma | Advanced Biliary Tract Carcinoma | Recruiting | Phase 2 | 2026-06-01 | NCT07036380 | |
| Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy | pancreatic adenocarcinoma | Not yet recruiting | Not applicable | 2026-04-23 | NCT07547033 | |
| Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-03-16 | NCT05528952 | |
| A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease | Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder | Active, not recruiting | Phase 3 | 2026-02-04 | NCT05662241 |